Physiologic and biochemical effects of ritodrine therapy on the mother and perinate

P. J. Hancock, Emmalee S Bandstra, S. N. Beydoun

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The materno-fetal and neonatal effects of ritodrine were studied in 37 women treated for premature labor with intravenous (i.v.) ritodrine. Marked cardiovascular, repsiratory, and biochemical side effects of therapy were seen in the mothers and tachycardia was noted in the fetuses. The neonates of 18 women in whom ritodrine successfully postponed delivery were delivered with good Apgar scores and their admission vital signs and nursery courses were benign. Ritodrine failed to delay delivery more than a week in 19 mothers. There were no differences between their newborns and 20 control neonates in admission vital signs, blood gases, blood chemistries, complete blood counts, platelet counts, peak bilirubin, or duration of oxygen therapy. This study revealed no deleterious effects on neonates delivered after maternal ritodrine therapy despite significant maternal and fetal effects.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalAmerican Journal of Perinatology
Volume2
Issue number1
StatePublished - Jan 1 1985

Fingerprint

Ritodrine
Mothers
Newborn Infant
Vital Signs
Therapeutics
Apgar Score
Blood Cell Count
Nurseries
Premature Obstetric Labor
Platelet Count
Bilirubin
Tachycardia
Fetus
Blood Platelets
Gases
Oxygen

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Physiologic and biochemical effects of ritodrine therapy on the mother and perinate. / Hancock, P. J.; Bandstra, Emmalee S; Beydoun, S. N.

In: American Journal of Perinatology, Vol. 2, No. 1, 01.01.1985, p. 1-6.

Research output: Contribution to journalArticle

@article{b438cd34394f4aad9c4efcbc1942e8e3,
title = "Physiologic and biochemical effects of ritodrine therapy on the mother and perinate",
abstract = "The materno-fetal and neonatal effects of ritodrine were studied in 37 women treated for premature labor with intravenous (i.v.) ritodrine. Marked cardiovascular, repsiratory, and biochemical side effects of therapy were seen in the mothers and tachycardia was noted in the fetuses. The neonates of 18 women in whom ritodrine successfully postponed delivery were delivered with good Apgar scores and their admission vital signs and nursery courses were benign. Ritodrine failed to delay delivery more than a week in 19 mothers. There were no differences between their newborns and 20 control neonates in admission vital signs, blood gases, blood chemistries, complete blood counts, platelet counts, peak bilirubin, or duration of oxygen therapy. This study revealed no deleterious effects on neonates delivered after maternal ritodrine therapy despite significant maternal and fetal effects.",
author = "Hancock, {P. J.} and Bandstra, {Emmalee S} and Beydoun, {S. N.}",
year = "1985",
month = "1",
day = "1",
language = "English",
volume = "2",
pages = "1--6",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",
number = "1",

}

TY - JOUR

T1 - Physiologic and biochemical effects of ritodrine therapy on the mother and perinate

AU - Hancock, P. J.

AU - Bandstra, Emmalee S

AU - Beydoun, S. N.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - The materno-fetal and neonatal effects of ritodrine were studied in 37 women treated for premature labor with intravenous (i.v.) ritodrine. Marked cardiovascular, repsiratory, and biochemical side effects of therapy were seen in the mothers and tachycardia was noted in the fetuses. The neonates of 18 women in whom ritodrine successfully postponed delivery were delivered with good Apgar scores and their admission vital signs and nursery courses were benign. Ritodrine failed to delay delivery more than a week in 19 mothers. There were no differences between their newborns and 20 control neonates in admission vital signs, blood gases, blood chemistries, complete blood counts, platelet counts, peak bilirubin, or duration of oxygen therapy. This study revealed no deleterious effects on neonates delivered after maternal ritodrine therapy despite significant maternal and fetal effects.

AB - The materno-fetal and neonatal effects of ritodrine were studied in 37 women treated for premature labor with intravenous (i.v.) ritodrine. Marked cardiovascular, repsiratory, and biochemical side effects of therapy were seen in the mothers and tachycardia was noted in the fetuses. The neonates of 18 women in whom ritodrine successfully postponed delivery were delivered with good Apgar scores and their admission vital signs and nursery courses were benign. Ritodrine failed to delay delivery more than a week in 19 mothers. There were no differences between their newborns and 20 control neonates in admission vital signs, blood gases, blood chemistries, complete blood counts, platelet counts, peak bilirubin, or duration of oxygen therapy. This study revealed no deleterious effects on neonates delivered after maternal ritodrine therapy despite significant maternal and fetal effects.

UR - http://www.scopus.com/inward/record.url?scp=0021927352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021927352&partnerID=8YFLogxK

M3 - Article

C2 - 3921037

AN - SCOPUS:0021927352

VL - 2

SP - 1

EP - 6

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 1

ER -